Figure 1.
Sonic hedgehog inhibitors developed via research using basal cell carcinoma (BCC), and now, these molecules are used in the treatment not only of metastatic and locally advanced BCC but, also, in treatment and research in a wide range of cancers, including breast cancer and pancreatic cancer [21].